Recent Advances of Metabolomics in Plant Biotechnology
Thursday, February 16, 2012
This article describes the basic analytical advancements in plant metabolomics and bioinformatics and the application of metabolomics to the biological study of plants.
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
Thursday, February 16, 2012
Company announced the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide.
DNAnexus Announces Strategic Alliances to Drive the Advancement of DNA-Based Medicine
Tuesday, February 14, 2012
Teams with top healthcare organizations Geisinger Health System and UCSF.
Bring a Buddy to ELA 2012
Monday, February 13, 2012
Select Biosciences, organisers of the Second European Lab Automation (ELA) at the Congress Center Hamburg, Germany from 30th-31st May 2012, is pleased to offer a ‘bring a buddy’ discount on conference registration fees.
Professor Andrew Morris Appointed Scotland's Chief Scientist
Monday, February 13, 2012
Professor Morris is co-Director of the Medical Research Institute at the University of Dundee and an internationally renowned expert in diabetes and health informatics.
INTERPHEX Unveils Conference Programming For May 2012 Event
Friday, February 10, 2012
This year’s conference and technical sessions will mark a new level of content, including new session criteria and formats, growth in the number of senior-level speakers, and a third day of programming.
Recombinant Data Named Finalist in "Most Promising Company" Competition
Thursday, February 09, 2012
Only software company to be nominated in the category at the Personalized Medicine World Conference 2012 (PMWC).
CLC bio and VIB Agree on an Academic Regional Site License
Thursday, February 09, 2012
Companies announced the signing of the site license agreement for CLC bio's sequence analysis software CLC DNA Workbench.
Applied Proteomics Appoints CEO Following Series B Financing
Wednesday, February 08, 2012
Applied Proteomics Inc. announce the appointment of Peter Klemm, Ph.D., as chief executive officer after securing $22.5 million Series B financing.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 468 |
|
|
